How to establish precise proprietary Chinese medicine in post-marketing reappraisal?

Journal Title: Traditional Medicine Research - Year 2017, Vol 2, Issue 4

Abstract

The clinical efficacy and safety of proprietary Chinese medicine has become a more prevailing public health concern. The China Food and Drug Administration has pushed drug companies to conduct post-marketing reappraisal for proprietary Chinese medicine to provide additional evidence supporting the efficacy and safety of these medicine. In this paper, we propose a reappraisal protocol called “precise proprietary Chinese medicine” to precisely i) define the therapeutic aim; ii) design the protocol; iii) control the quality of proprietary Chinese medicine; iv) implement the protocol in the trial; v) study the mechanism-of-action of the proprietary Chinese medicine and vi) describe the indications of the proprietary Chinese medicine. We hope that these steps facilitate the post-marketing reappraisal of proprietary Chinese medicine.

Authors and Affiliations

Tian Ran, Dai Liang, Shang Hong-Cai, Li You-Ping, Bian Zhao-Xiang

Keywords

Related Articles

Chen Shi Yang Xue An Shen Tang

Sheng Long Chi (Apatite) 30g, Chao Suan Zao Ren (Semen Ziziphi Spinosae) 15g, Jiao Yuan Zhi (Radix Polygalae) 10g, Zhi Shou Wu (Radix Polygoni Multiflori Preparata) 10g, Gou Qi Zi (Lycium barbarum) 10g, Bai Shao (Radix P...

Network pharmacology-based approach to investigate the mechanism of Huang-Lian-Jie-Du-Decoction for treatment of type 2 diabetes mellitus

Background: Although the benefits of Huang-Lian-Jie-Du-Decoction (HLJDD) on type 2 diabetes mellitus are noted, the material base and action mechanism remain unknown. This paper aim is to reveal the material base and act...

Nephrotoxicity and carcinogenesis of aristolochic acids and their derivates

Aristolochic acids (AAs), a natural mixture of 8-methoxy-6-nitro-phenanthro-(3,4-d)-1,3-dioxolo-5-carboxylic acid (AAI) and 6-nitro-phenanthro-(3,4-d)-1,3-dioxolo-5-carboxylic acid (AAII), derived from aristolochiaceae s...

Omics technology: an important tool in mechanism studies of Chnese herbal formulas

Identifying the active ingredients from natural herbal medicines and demonstrating their potential mechanisms are key points in the traditional Chinese medicine (TCM) field. In recent years, increasing studies have focus...

The marriage of Chinese Imperial Medicine and China Academy of Chinese Medical Sciences: privilege and benefits for the people

On September 27, 2019, the Palace Museum and China Academy of Chinese Medical Sciences held a signing ceremony of strategic cooperation at Jingsheng Zhai (The studio of esteemed excellence) in the garden of Jianfu Gong (...

Download PDF file
  • EP ID EP45249
  • DOI 10.12032/TMR201708054
  • Views 273
  • Downloads 0

How To Cite

Tian Ran, Dai Liang, Shang Hong-Cai, Li You-Ping, Bian Zhao-Xiang (2017). How to establish precise proprietary Chinese medicine in post-marketing reappraisal?. Traditional Medicine Research, 2(4), -. https://europub.co.uk/articles/-A-45249